29089QAB1

Emergent Biosolutions Inc.

Could not find a ticker for this position, may be a filing error

A specialty biopharmaceutical company that makes medicines to protect against biological threats and opioid overdoses. Its best-known products include BioThrax, a vaccine against anthrax, and NARCAN, a nasal spray that reverses opioid overdoses and became the first naloxone product sold over the counter without a prescription. Founded in 1998 as BioPort, the company took over Michigan's anthrax vaccine facilities and later renamed itself Emergent BioSolutions, a nod to its role in helping people emerge from public health emergencies.

2.875% Convertible Senior Notes due 2021